lundi 22 février 2016

Valeant shares sink following negative analyst report

Valeant Philidor 20151030

Shares of Valeant Pharmaceuticals have slumped for the second straight trading day, erasing more than $6 billion US of market value from the drug company since last Thursday.

0 commentaires:

Enregistrer un commentaire